US2014274949A1PendingUtilityA1

Personal care compositions

Assignee: PROCTER & GAMBLEPriority: Mar 15, 2013Filed: Mar 14, 2014Published: Sep 18, 2014
Est. expiryMar 15, 2033(~6.6 yrs left)· nominal 20-yr term from priority
A61K 31/715A61K 8/345C11B 9/0069A61Q 13/00A61K 8/738A61K 8/362A61K 8/34A61K 2800/30A61K 31/724A61Q 15/00A61K 8/046
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition suitable for topical application, for example, is provided. In some examples, the composition can include particular cyclic oligosaccharides, a fragrance, and a volatile solvent. The compositions disclosed herein may provide a longer lasting fragrance.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A feminine or adult incontinence spray composition, the composition comprising:
 a cyclic oligosaccharide selected from the group consisting of a water-soluble cyclic oligosaccharide, an ethanol-soluble cyclic oligosaccharide, a water- and ethanol-soluble cyclic oligosaccharide, and mixtures thereof;   i) a fragrance;   ii) a volatile solvent; and   iii) a nonvolatile solvent;   wherein the weight ratio of the nonvolatile solvent to the cyclic oligosaccharide is less than 1:1.   
     
     
         2 . The spray of  claim 1 , wherein the composition comprises water- and ethanol-soluble cyclic oligosaccharide. 
     
     
         3 . The spray of  claim 2 , wherein the composition comprises from about 0.75% to about 5% of the water- and ethanol-soluble cyclic oligosaccharide by weight of the composition. 
     
     
         4 . The spray of  claim 1 , wherein the fragrance comprises a fragrance composition comprising more than 30%, by weight of the fragrance composition, of perfume aldehydes at least 10% of which having a Thiol Vapor Pressure Suppression index of greater than 20. 
     
     
         5 . The spray of  claim 2 , wherein the water- and ethanol-soluble cyclic oligosaccharide is selected from the group consisting of hydroxypropyl-α-cyclodextrin, hydroxylpropyl-β-cyclodextrin, methyl-α-cyclodextrin, methyl-β-cyclodextrin, and mixtures thereof. 
     
     
         6 . The spray of  claim 2 , wherein the water- and ethanol-soluble cyclic oligosaccharide comprises methyl-β-cyclodextrin. 
     
     
         7 . The spray of  claim 1 , wherein the nonvolatile solvent is selected from the group consisting of benzyl benzoate, diethyl phthalate, triethyl citrate, propylene glycol, isopropyl myristate, dipropylene glycol, panthenol, panthenyl triacetate, and mixtures thereof. 
     
     
         8 . The spray of  claim 1 , wherein the composition comprises greater than 60% of the volatile solvent by weight of the composition. 
     
     
         9 . The spray of  claim 1 , wherein the composition comprises from about 0.5% to about 5% of the nonvolatile solvent by weight of the composition. 
     
     
         10 . The spray of  claim 1 , further comprising a Vitamin B5 derivative. 
     
     
         11 . A feminine or adult incontinence spray composition, the composition comprising:
 a cyclic oligosaccharide selected from the group consisting of a water-soluble cyclic oligosaccharide, an ethanol-soluble cyclic oligosaccharide, a water- and ethanol-soluble cyclic oligosaccharide, and mixtures thereof;   i) a fragrance;   ii) a volatile solvent; and   iii) a nonvolatile solvent comprising a Vitamin B5 derivative;   wherein the weight ratio of the nonvolatile solvent to the cyclic oligosaccharide is less than 1:1, and wherein the composition comprises greater than 60% of the volatile solvent by weight of the composition.   
     
     
         12 . The spray of  claim 11 , wherein the fragrance comprises a fragrance composition comprising more than 30%, by weight of the fragrance composition, of perfume aldehydes having a Thiol Vapor Pressure Suppression index of greater than 20. 
     
     
         13 . The spray of  claim 11 , wherein the composition comprises greater than 80% of the volatile solvent by weight of the composition. 
     
     
         14 . The spray of  claim 11 , wherein the composition comprises greater than 90% of the volatile solvent by weight of the composition. 
     
     
         15 . A method for providing a fragrance composition in conjunction with wearing a feminine hygiene article or adult incontinence article, the method comprising the steps of:
 a) providing a spray composition comprising a cyclic oligosaccharide selected from the group consisting of a water-soluble cyclic oligosaccharide, an ethanol-soluble cyclic oligosaccharide, a water- and ethanol-soluble cyclic oligosaccharide, and mixtures thereof;
 i) a fragrance; 
 ii) a volatile solvent; and 
 iii) a nonvolatile solvent; 
 wherein the weight ratio of the nonvolatile solvent to the cyclic oligosaccharide is less than 1:1; 
   b) spraying an amount of the spray composition onto at least one of the exterior surface of a pre-purchased feminine hygiene article or adult incontinence article, and the body; and   c) wearing the feminine hygiene article or adult incontinence for a period of time, during which at least some of the fragrance is released from the spray composition.   
     
     
         16 . The method of  claim 15 , wherein the nonvolatile solvent comprises a Vitamin B5 derivative. 
     
     
         17 . The method of  claim 15 , wherein the fragrance comprises a fragrance composition comprising more than 30%, by weight of the fragrance composition, of perfume aldehydes at least 10% of which having a Thiol Vapor Pressure Suppression index of greater than 20. 
     
     
         18 . The method of  claim 15 , wherein the spray composition comprises greater than 80% of the volatile solvent by weight of the spray composition. 
     
     
         19 . The method of  claim 15 , wherein the spray composition comprises greater than 90% of the volatile solvent by weight of the spray composition.

Join the waitlist — get patent alerts

Track US2014274949A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.